HR Guru Mayank Rautela offers practical advice.
The category is expected to cross Rs 38,400 crore by 2020.
HR Guru Mayank Rautela offers practical advice.
HR Guru Mayank Rautela offers practical advice.
HR Guru Mayank Rautela offers practical advice.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Mayank Rautela distils his 20-odd years of experience in human resources management to tell you how you can ace in your career.
Global private equity (PE) major Carlyle is in talks with renowned cardiac surgeon Dr Naresh Trehan to acquire a minority stake in his Gurgaon-based multi-super speciality hospital, Medanta -The Medicity.
HR guru Mayank Rautela has some suggestions.
What do you do when you've lost your job during the lockdown and are unable to get another one? Get expert advice from HR Guru Mayank Rautela.
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
HR Guru Mayank Rautela offers practical advice.
HR Guru Mayank Rautela offers practical advice.
Working online is the new reality, explains HR Guru Mayank Rautela.
How do you decide if you should take up a new job in these difficult times? HR guru Mayank Rautela has some tips that could help you decide.
'We need to confront such people else they will be encouraged to harass more women in the future,' notes HR guru Mayank Rautela.
HR guru Mayank Rautela provides a three-point plan.
Irrespective of demonetisation and GST blues, IIM Lucknow has been able to successfully place their batch of 459 students.
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
Financial numbers can sometimes paint a rosy picture because of changes in the accounting policy or a one-time income.
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.
Markets end higher ahead of Fed outcome, China stimulus
Launches of new homes reduced drastically this year.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
The industry's reactions to the Budget have been mixed.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances